Fig. S1. the Non-Coding Transcriptome Is a Key Component of the TGF-Β Response of Lung Fibroblasts

Fig. S1. the Non-Coding Transcriptome Is a Key Component of the TGF-Β Response of Lung Fibroblasts

Fig. S1. The non-coding transcriptome is a key component of the TGF-β response of lung fibroblasts. Circos plot showing the genome-wide transcriptional profiling of TGF-β-regulated mRNAs and ncRNAs in lung fibroblasts (Datasets 1 and 2). (b,d,f) Log2 FoldChange of differentially expressed lncRNAs (d), protein-coding genes near to lincRNA candidate loci (<500kb) (b), and miRNAs (f). Upregulated and downregulated genes are shown in red and green respectively. (a,c,e) Associated protein-coding gene names (a), lncRNA names (c) colored according to their biotype: lincRNAs (orange), primiRNAs (green), antisense RNAs (turquoise), pseudogenes (blue), and mature miRNA names (e). (g,h) Inner links representing local lncRNAs-protein-coding genes (black) and lncRNAs-miRNAs (blue) co-regulation associations. Lung Fibroblasts TGF-β, RNA sequencing Chr1 n o A B i s 1000 s e r ** p 800 x Control e Control TGF-β S TGF-β O 600 3 M N 400 D d e z 200 i l a m r 0 o N Control TGF-β Lung fibroblasts, DNM3OS Gapmer TGF-β C DNM3OS E ACTA2 F 3 ## 25 ## 1 0 n * * n n * o ** 8 i 20 o o i s i s s s s a e 2 r e v 6 r 15 p n p I x x e e e v e 10 i 4 e t v i v a t i 1 l t * a e l a ** l e 5 R 2 e R R ** * 0 0 0 Control TGF- C o n tro l T G F - Control TGF- Gp Control Gp control ## Gp DNM3OS 3 COL1A1 Gp DNM3OS n ** o i s s 2 e D r p x e TGF-β - TGF-β + e v i 1 t Gp DNM3OS Control DNM3OS Control a l * e * R 0 Control TGF- 4 FN1 ## n * o i s 3 s e r p x 2 e e v i t a l 1 e R 0 Control TGF- Gp DNM3OS Gp control Fig. S2. Identification of DNM3OS as a key effector of TGF-β signaling. (A) Screenshot from Integrative Genomic Viewer displaying representative RNA-Seq data of the DNM3OS locus (Dataset 1). An increase of total reads associated with the unprocessed transcript (variant 1, long non-coding RNA, 7,957 bp lncRNA, NR_038397.2) and the spliced transcript (variant 2, 4,051 bp linear ncRNA, lncRNA, NR_103486.1) following TGF-β treatment is shown. (B) Bar charts showing the normalized expression of DNM3OS in control or TGF-β stimulated cells. Data from high- throughput sequencing are expressed as normalized counts ± SEM for three independent experiments. ** P<0.01. (C-F) Functional impact of DNM3OS silencing on TGF-β signaling in pulmonary fibroblasts. MRC5 cells were transfected with either a control or a DNM3OS-specific gapmer (Gp) and then incubated with or without TGF-β (C) Bar charts showing the relative expression of DNM3OS in the indicated conditions. Data are expressed as mean ± SEM. (n=3) * P<0.05 ** P<0.01 ## P<0.01. (D) Heatmap comparing the normalized log2 expression of significantly modulated transcripts obtained by microarray analysis (n=2 per group, Dataset 3). (E) Bar charts showing the relative expression of ACTA2 (α-SMA) COL1A1 and FN1 compared to PPIA in the indicated conditions. Data are expressed as mean ± SEM. (n=3) * P<0.05 ** P<0.01 ## P<0.01. (F) Bar charts showing the relative quantification of invasion in the indicated conditions. Data are expressed as mean ± SEM (n=3). ** P<0.01. Lung Fibroblasts TGF-β, small RNA sequencing miRNA GOF / LOF FN1 A D 2.5 n o i s 2.0 ** Control s ** RNA-Seq e TGF-β r p 1.5 Control x e Small RNA-Seq TGF-β e 1.0 v i t a l 0.5 e miR-199a-3p R miR-199a-5p 0.0 l p p p o 3 3 5 r - - Pre-miR - t 4 a a n 1 9 9 o 2 9 9 - C 1 1 - - R i R R i i Control m m RNA-Seq m TGF-β Small RNA-Seq Control TGF-β FN1 4 miR-214-3p n o i s ** s 3 e ** r p x 2 e e v i Lung Fibroblasts TGF-β, qPCR t 1 a l e B C R 0 2.5 miR-199a-3p 2 .5 miR-199a-3p TGF-β - - - + - + * * l + + p p p o 3 3 5 r n n - - - t 4 a a o o 2 .0 n * i i 2.0 1 9 LNA 9 o s s 2 9 9 - C s s 1 * * 1 - - R e e i r r R * 1 .5 R i 1.5 i p p m x m m x e e e e 1.0 1 .0 v v i i t t a a l l E 6 e e 0.5 0 .5 R n R ** o i s ** 0.0 0 .0 a 4 TGF-β (ng/mL) 0 5 10 20 TGF-β (h) 0 6 1 2 2 4 v n i e v i 3.0 miR-199a-5p 2 .5 miR-199a-5p t 2 a l * e n n * 2.5 R o o 2 .0 i i * s s 0 s s l p p p 2.0 e e o r 3 r 5 * 3 r - - 1 .5 - t p p Pre-miR 4 a a n x x 1 9 * 9 1.5 * o e e 2 9 9 - C 1 1 e e - 1 .0 - R v i v i R R i i i 1.0 t t m a a 30 m m l l ** e e 0 .5 n 0.5 R R o i s 0.0 0 .0 a 20 v TGF-β (ng/mL) 0 5 10 20 TGF-β (h) 0 6 1 2 2 4 n ** I e v i 2 .5 3 .0 t 10 miR-214-3p miR-214-3p * a l * * e n n * * 2 .5 R o 2 .0 o i i s s 0 s s 2 .0 e e * r 1 .5 r TGF-β - + - + - + - + * l p p p p p o x x 3 3 5 r - - 1 .5 - t e e * 4 a a LNA n e 1 e 9 9 1 .0 o 2 v 9 9 v i - i C 1 1 .0 1 t t - - R a a i l l R R i i e e 0 .5 m m 0 .5 m R R 0 .0 0 .0 TGF-β (ng/mL) 0 5 1 0 2 0 TGF-β (h) 0 6 1 2 2 4 Fig. S3. DNM3OS is processed into three profibrotic miRNAs in lung fibroblasts. (A) Screenshot from IGV browser displaying representative small RNA-Seq data of the DNM3OS locus in TGF-β-exposed human pulmonary fibroblasts or control conditions (Dataset 2). Zoomed in view of the regions corresponding to miR-199a2 and miR-214, which shows, in response to TGF-β, an increase number of reads associated with the following mature miRNAs: miR-199a-3, miR-199a-5p and miR-214-3p. As the expression of miR-214-5p represents only 5% of the total reads of miR-214, this miRNA was not considered relevant. (B,C) Bar charts showing dose-(B) and time-dependent (C) expression of DNM3OS-associated miRNAs in MRC5 cells exposed or not to TGF-β. RNU44 was used as reference. Data are expressed as mean ± SEM (n=3). * P<0.05 ** P<0.01. (D) Bar charts showing the relative expression of FN1 compared to PPIA in the indicated condition. Data are expressed as mean ± SEM. (n=3) ** P<0.01. (E) Bar charts showing the relative quantification of invasion in the indicated conditions. Data are expressed as mean ± SEM (n=3). ** P<0.01. A B miR-199a-3p miR-199a-5p miR-214-3p miR-199a-3p NES=2.04 miR-199a-5p NES=4.61 miR-214-3p NES=4.58 C D miR-199a-3p miR-199a-5p miR-214-3p log10 P. Value P. log10 Value P. log10 Value P. log10 - - - Fold Enrichment Fold Enrichment Fold Enrichment E Target identification GSK3B Mimics GOF miRonTop miR-214-3p PTGS2 FGF7 Gapmer LOF Fibrotic TargetScan miR-199-3p pathways & TGF-β Mungunsukh and Day, stimulation HGF (IPA) 2013a Lino Cardenas et al., miR-199a-5p CAV1 2013 Fig. S4. Identification of the cellular pathways and gene targets associated with the miR-199a~214 cluster in human lung fibroblasts. (A) Heatmap showing the genes differentially expressed after individual miRNA mimics overexpression in lung fibroblasts (dataset 4). (B) GSEA plots of an experimental TGF-β-signature (Dataset 5) showing a significant enrichment of miR-199a-5p and miR-214-3p down-regulated transcripts. Genes whose expression is downregulated after miRNA mimics overexpression were compared to an experimental TGF-β signature obtained in the same cells (MRC5 cells). TGF-β signature consists of 368 transcripts downregulated in response to TGF-β (log2 ratio <-1, adj.p value<0.01). In each case, graphs show the enrichment plot, the score at the peak corresponding to the ES and the position of the TGF-β gene set in the ranked list of genes (each transcript is indicated by a vertical bar). (C,D) Overrepresentation of miRNA predicted targets in the set of downregulated transcripts following miR-199a-5p/3p and miR-214-3p transfection using (C) Ingenuity Pathway Analysis and (D) the webtool miRonTop.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    26 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us